Matthew Maxwell Donley

Matthew Maxwell Donley has an estimated net worth of $14.4 Million. This is based on reported shares across multiple companies, which include Aurinia Pharmaceuticals Inc., and Sucampo Pharmaceuticals, Inc..

2017 was Matthew Maxwell Donley's most active year for acquiring shares with 6 total transactions. Matthew Maxwell Donley's most active month to acquire stocks was the month of February. 2018 was Matthew Maxwell Donley's most active year for disposing of shares, totalling 6 transactions. Matthew Maxwell Donley's most active month to dispose stocks was the month of January. 2021 saw Matthew Maxwell Donley paying a total of $99,738.54 for 9,900 shares, this is the most they've acquired in one year. In 2018 Matthew Maxwell Donley cashed out on 415,975 shares for a total of $3,561,990.00, their largest year based on trade value.